Erratum: “Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice,”(National Academy of Sciences(2019)116( 21727–21731)Doi:10.1073/pnas.1911321116);Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 116, Issue 43, 2019, Pages 21727-21731

  Tang, Moon shong ^a   Wu, Xue Ru ^a   Lee, Hyun Wook ^a   Xia, Yong ^a   Deng, Fang Ming ^a   Moreira, Andre L ^a   Chen, Lung Chi ^a   Huang, William C ^a   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder hyperplasia; DNA damage; DNA repair; Electronic cigarette; Lung cancer

Indexed keywords

CIGARETTE SMOKE; DNA; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DISEASE; BLADDER UROTHELIAL HYPERPLASIA; CANCER INCIDENCE; CARCINOGENICITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL EXPOSURE; HYPERPLASIA; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADVERSE EVENT; ANIMAL; BLADDER; DRUG EFFECT; ELECTRONIC CIGARETTE; LUNG; LUNG TUMOR; PATHOLOGY; SMOKE; SMOKING; UROTHELIUM;

ADENOCARCINOMA OF LUNG; ANIMALS; DNA DAMAGE; DNA REPAIR; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HYPERPLASIA; LUNG; LUNG NEOPLASMS; MALE; MICE; NICOTINE; SMOKE; SMOKING; URINARY BLADDER; UROTHELIUM;

EID: 85073755341     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1918000116     Document Type: Erratum

References (24)

1. N. L. Benowitz, Nicotine addiction. N. Engl. J. Med. 362, 2295–2303 (2010).
2. S. S. Hecht, D. Hoffmann, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875–884 (1988).
3. S. S. Hecht, Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91, 1194–1210 (1999).
4. N. Howlader et al., Eds., SEER Cancer Statistics Review, 1975-2014 (National Cancer Institute, Bethesda, MD, 2016). https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER website, April 2017. Accessed 2 April 2018.
5. R. Grana, N. Benowitz, S. A. Glantz, E-cigarettes: A scientific review. Circulation 129, 1972–1986 (2014).
6. P. Hajek et al., A randomized trial of E-cigarettes versus nicotine-replacement therapy. N. Engl. J. Med. 380, 629–637 (2019).
7. S. S. Hecht, DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res. 424, 127–142 (1999).
8. S. S. Hecht, S. G. Carmella, P. G. Foiles, S. E. Murphy, L. A. Peterson, Tobacco-specific nitrosamine adducts: Studies in laboratory animals and humans. Environ. Health Perspect. 99, 57–63 (1993).
9. L. Shahab et al., Nicotine, carcinogen, and toxin exposure in long-term E-cigarette and nicotine replacement therapy users: A cross-sectional study. Ann. Intern. Med. 166, 390–400 (2017).
10. S. A. Glantz, D. W. Bareham, E-cigarettes: Use, effects on smoking, risks, and policy implications. Annu. Rev. Public Health 39, 215–235 (2018).
11. D. T. Levy et al., Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tob. Control 27, 18–25 (2018).
12. H. W. Lee et al., E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc. Natl. Acad. Sci. U.S.A. 115, E1560–E1569 (2018).
13. J. Zhao, G. Pyrgiotakis, P. Demokritou, Development and characterization of electronic-cigarette exposure generation system (Ecig-EGS) for the physico-chemical and toxicological assessment of electronic cigarette emissions. Inhal. Toxicol. 28, 658–669 (2016).
14. US Department of Health and Human Services, The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2006).
15. US Department of Health and Human Services, The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General (Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2014).
16. J. Van Batavia et al., Bladder cancers arise from distinct urothelial sub-populations. Nat. Cell Biol. 16, 982–991, 1–5 (2014).
17. K. Saeb-Parsy et al., Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine. Br. J. Cancer 107, 1384–1391 (2012).
18. H. J. Haussmann, M. W. Fariss, Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit. Rev. Toxicol. 46, 701–734 (2016).
19. T. Sanner, T. K. Grimsrud, Nicotine: Carcinogenicity and effects on response to cancer treatment–A review. Front. Oncol. 5, 196 (2015).
20. S. A. Grando, Connections of nicotine to cancer. Nat. Rev. Cancer 14, 419–429 (2014).
21. H. L. Waldum et al., Long-term effects of inhaled nicotine. Life Sci. 58, 1339–1346 (1996).
22. E. L. Floyd, L. Queimado, J. Wang, J. L. Regens, D. L. Johnson, Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol. PLoS One 13, e0210147 (2018).
23. H. W. Lee et al., Cigarette side-stream smoke lung and bladder carcinogenesis: Inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation. Oncotarget 6, 33226–33236 (2015).
24. M. W. Weng et al., Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 115, E6152–E6161 (2018).